Empowering Primary Care Through Evidence

PEER is a primary care led evidence based medicine team focused on providing relevant evidence to family physicians and primary care providers.

The PEER Simplified Lipid Guideline

Updated for 2023! A simplified approach to lipid management for busy family doctors! Practical summary for clinicians. Evidence-based recommendations for lipid management. Useful online decision aid. Easy-to-read patient handout.

CFPCLearn’s primary care focused library includes a variety of content including evidence summaries, videos, podcasts and interactive learning courses to support clinicians in their practice.

PEIP Conference 2023

Another great PEIP conference occurred October 20-21, 2023. 

 We had over 600 attendees, both in-person and online, who enjoyed the mixture of concise, to-the-point presentations which blended humour with serious learning.  We were thrilled to have outstanding speakers who focused on practical, applicable knowledge.  From “Bodies Behaving Badly” to practical sessions on Orthopedics, the diversity and richness of content offered something valuable for all primary care professionals. 

We’re excited to announce that PEIP 2024 is scheduled for October 18-19, 2024. Whether you prefer to join us in person or online, we promise another round of engaging, insightful, and fun sessions.

Most Recent Tools for Practice

Tools for Practice #366 Looking for Closure: Managing simple excisions or wounds efficiently

What are some options for efficiency in wound closure?

Punch biopsies 4mm do not require closure but 8mm do. Skin-glue is similar to tape or sutures for simple wounds for clinician-rated cosmesis and patient satisfaction with similar infection rates of 4-7%. However, dehiscence occurs in ~5% with skin-glue compared to 1% with suture. Absorbable sutures have similar outcomes to non-absorbable sutures. Read More

Tools for Practice #365 Shrooms for Glooms: Evidence for psilocybin for depression

What are the benefits and harms of psilocybin for treatment-resistant/recurrent depression?

Psilocybin, given in treatment facilities with >10 hours psychological support, improves short-term (≤6 weeks) depression scores, helping 20-30% more patients attain response over control. Effects biased by unblinding, short-term trials and mostly inactive comparators. Psychological distress during treatment is common (75-90%) and requires monitoring/supports. Read More

Tools for Practice #364 Facing the Evidence in Acne, Part II: Oral Antibiotics

How effective are oral antibiotics in treating acne of at least mild-moderate severity?

Approximately 17% of patients achieve “success” on oral minocycline versus 9% on placebo at 12 weeks. Oral antibiotics reduce acne lesion count by 10-24% more than placebo. Evidence of the efficacy of adding oral antibiotics to topical agents (example: retinoids, benzoyl peroxide) is limited. Efficacy appears similar between individual antibiotics. Discontinuations due to adverse events are comparable to placebo. Read More

Tools for Practice #363 Making a difference in indifference? Medications for apathy in dementia

In patients with dementia, how safe and effective are stimulants, antidepressants, and antipsychotics for treating apathy?

Methylphenidate may improve apathy scores by a small but potentially clinically meaningful amount compared to placebo (example: 5 points more on a 72-point scale) at ~12 weeks. Methylphenidate does not impact cognition in randomized, controlled trials (RCTs). Antipsychotics and antidepressants do not improve apathy compared to placebo. Read More

Tools for Practice #362 – Facing the Evidence in Acne, Part I: Oral contraceptives and spironolactone in females

How effective are combined oral contraceptives (COC) and spironolactone for treating acne of at least mild-moderate severity in females?

At ~24 weeks, ~80-90% of females report improvement in their acne with COCs, compared to 50-80% placebo, and 30-50% will have clear-almost clear skin versus 10-40% on placebo. Efficacy appears similar between individual COCs. Spironolactone, typically added to topical agents, has similar outcomes. Discontinuations due to adverse events appear comparable to placebo. Read More

Congratulations to PEER's Tina Korownyk: Alberta Family Physician of the Year

PEER Director, Dr. Tina Korownyk was awarded the 2023 Alberta Family Physician of the year at the annual Family Medicine Forum gala in Montreal, Quebec on November 10. The PEER team joined Tina to celebrate her achievement as a wonderful physician and leader in primary care. Congratulations Tina!

PEER Values

When creating primary care education and programs, the PEER team focuses on minimizing bias, patient orientated outcomes, shared decision making, collaboration and most importantly simplicity.

Who is PEER?

Patients, Experience, Evidence and Research (PEER) was formed between a group of primary care providers who shared a common belief that evidence should be made accessible to all primary care providers. 

Follow @peerevidence on Instagram

Our Partners

Sign Up for the PEER Newsletter

Don’t miss out on the latest from PEER. Get first access the latest PEER research and notified when PEER releases new guidelines and tools.